Cargando…
Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
Colorectal cancer (CRC) is one of the leading causes of tumor-related death worldwide. While surgery can cure patients with early stage CRC, the 5-year survival rate is only 10% for patients with metastatic disease. Therefore, new anti-metastatic therapies are needed for this cancer. Metastatic spre...
Autores principales: | Lafitte, Marie, Sirvent, Audrey, Roche, Serge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028753/ https://www.ncbi.nlm.nih.gov/pubmed/32117772 http://dx.doi.org/10.3389/fonc.2020.00125 |
Ejemplares similares
-
New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance
por: Sirvent, Audrey, et al.
Publicado: (2022) -
DDR1 inhibition as a new therapeutic strategy for colorectal cancer
por: Sirvent, Audrey, et al.
Publicado: (2018) -
Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis
por: Sirvent, Audrey, et al.
Publicado: (2020) -
Control of Tyrosine Kinase Signalling by Small Adaptors in Colorectal Cancer
por: Mevizou, Rudy, et al.
Publicado: (2019) -
Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets
por: Piran, Mehran, et al.
Publicado: (2021)